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Objectives: To investigate whether EndoVascular Aneurysm Repair
(EVAR) influences the rate of cardiovascular events (fatal or non-fatal
myocardial infarction or stroke) in patients with abdominal aortic aneurysm
(AAA) considered unfit for open repair.
Design: Randomised controlled trial.
Materials: Between 1999 and 2004, 404 patients with large AAA
considered unfit for open repair were randomised to EVAR or no surgical
intervention across 33 UK hospitals and followed until July 2009.
Methods: The Customised Probability Index was used to determine
fitness for each patient and Cox regression was used to compare time to first
cardiovascular event between randomised groups and levels of fitness.
Results: During an average of 2.8 years of follow-up, 67 first cardio-
vascular events occurred with a non-significantly higher event rate in the
EVAR group compared to the no intervention group (6.6 versus 5.1 events
per 100 person years); adjusted hazard ratio 1.42 [95% CI 0.87–2.34],
p  0.156. There was no evidence to suggest that the hazard ratio between
randomised groups changed with level of fitness (p  0.378).
Conclusions: Cardiovascular event rates were high in these unfit
patients and medical therapy was sub-optimal. Events rates were slightly
higher in the EVAR group but this was not statistically significant.
Analysis of Outcome after Using High-risk Criteria Selection to Sur-
gery Versus Endovascular Repair in the Modern Era of Abdominal
Aortic Aneurysm Treatment
Steinmetz E., Abello N., Kretz B., Gauthier E., Bouchot O., Brenot R. Eur
J Vasc Endovasc Surg 2010;39:403-9.
Introduction: The concept of high-risk patients suggests that such
patients will experience a higher rate of postoperative complications and
worse short- and long-term outcomes, and should therefore benefit from the
use of endovascular techniques for aortic abdominal aneurysm (AAA) repair.
The primary goal of this study was to assess the relevance of the different
high-risk criteria, defined by the French health agency Agence Française de
Sécurité Sanitaire des Produits de Santé (AFSSAPS) in a single-centre
continuous series. Secondary goals were to retrospectively compare the
incidence of postoperative complications and short- and long-term survival
in three groups of patients.
Materials and methods: Between January 1999 and December 2006,
details of all the patients undergoing elective surgery for AAA in our hospital
were recorded into a prospective registry (n  626). Three groups were
considered according to the level of risk and type of repair defined by the
AFSSAPS: endovascular aortic aneurysm repair (EVAR) high-risk (HR) (at
least one high-risk factor and EVAR, n  138), open HR (at least one
high-risk factor and open repair, n  134) and open low-risk (LR) (no
high-risk factors and open repair, n  344). None of the low-risk patients
were treated using an endovascular approach. The demographics, preoper-
ative risk factors, intra-, postoperative data and short- and long-term survival
were compared between the groups. Interrelations among the set of high-
risk criteria for mortality were calculated using multiple correspondence
analysis (MCA).
Results: The distribution of high-risk criteria was similar in both
high-risk groups, except for age, heart failure and hostile abdomen, which
were significantly more frequent in EVAR HR. Operation time, blood loss
and length of stay in an intensive care unit and hospital were significantly
lower in the EVAR HR group. The 30-day mortality and survival rates at
5 years were 5.4 and 59.4% for EVAR HR, 3.7 and 70.4% for open HR and
2.3 and 83.7% for open LR, respectively, with no significant difference
between the three groups for the mortality, but a significant higher survival
at 5 years for the open LR versus both high-risk groups.
Conclusion: The high-risk AFSSAPS criteria were not predictive of
postoperative mortality and should not be used to determine the choice of
treatment technique. Other criteria therefore need to be established to
determine whether open or EVAR repair should be used.
1066Duplex Ultrasound and Contrast-Enhanced Ultrasound Versus Com-
puted Tomography for the Detection of Endoleak after EVAR: Sys-
tematic Review and Bivariate Meta-Analysis
Mirza T.A., Karthikesalingam A., Jackson D., Walsh S.R., Holt P.J., Hayes
P.D., Boyle J.R. Eur J Vasc Endovasc Surg 2010;39:418-28.
Introduction: Contrast-enhanced computed tomography (CT) has
become the ‘gold-standard’ imaging modality for surveillance following
EVAR. However repeated CT causes cumulative contrast related renal
injury. Duplex ultrasound (USS) and contrast-enhanced (non-nephrotoxic)
duplex scanning (CEUS) are less invasive but considered less accurate than
CT. The aim of this study was to determine the diagnostic accuracy of
imaging modalities used to detect endoleak. Accordingly, we undertook a
systematic review and meta-analysis of the evidence base for USS and CEUS
compared to CT following EVAR.
Methods: Medline, Embase, trial registries, conference proceedings
and article reference lists were searched to identify trials comparing USS or
CEUS with CT following EVAR. Contrast-enhanced computed tomogra-
phy was taken as the ‘gold-standard’ investigation. USS and CEUS were
compared to CT in separate meta-analyses.
Results: Twenty-one studies in 2601 patients compared USS with CT.
The sensitivity of USS at detecting endoleak was 0.77 (95% CI 0.64–0.86;
I2  0.82) and pooled specificity 0.94 (95% CI 0.88–0.97; I2  0.90).
Seven studies (288 patients) compared CEUS vs CT. The pooled sensitivity
was 0.98 (95% CI 0.90–0.99; I2  0.32) and specificity 0.88 (95% CI
0.78–0.94; I2  0.67).
Conclusion: This study confirms that unenhanced USS has poor
sensitivity for endoleak detection; however CEUS is a highly sensitive
modality. These results should be interpreted with some caution due to
heterogeneity in analysed trials and further research is needed to evaluate the
efficacy of CEUS before it can be utilised as the primary imagingmodality for
EVAR surveillance.
Impact of Long-term Corticosteroid Therapy on the Distribution
Pattern of Lower Limb Atherosclerosis
Willenberg T., Diehm N., Zwahlen M., Kalka C., Do D.-D., Gretener S.,
Ortmann J., Baumgartner I. Eur J Vasc Endovasc Surg 2010;39:441-6.
Objective: Ectopic calcification and mediacalcinosis can be promoted
by corticosteroid use. Aim of the present investigation is to describe macro-
vascular disease features in patients with long-term corticosteroid therapy
and symptomatic lower limb peripheral arterial occlusive disease (PAD).
Methods: A consecutive series of 2783 patients undergoing clinical
and angiographic work-up of PAD were screened for long-term (5 years)
corticosteroid use (group A). Comparison was performed to a randomly
selected age-, sex- and risk factor-matched PAD control cohort from the
same series without corticosteroid use (group B). Patients with diabetes
mellitus or severe renal failure were excluded. Arterial calcification was
evaluated by qualitative assessment on radiographic images. Severity of
atherosclerotic lesions was analysed from angiographic images using a semi-
quantitative score (Bollinger score).
Results: In general, 12 patients (5 males, mean age 78.5  9.0 years)
with 15 ischaemic limbs qualified to be enrolled in group A and were
compared to 23 matching control patients (6 2males, mean age 79.5  6
years) with 32 ischaemic limbs. Incompressibility of ankle arteries deter-
mined by measurement of the ankle-brachial index was seen in 12 limbs
(80%) in group A compared to 3 limbs (9%) in group B (p  0.0009). No
significant difference was found comparing group A and B for segmental
calcification, whereas comparison of the atherosclerotic burden using the
angiographic severity score showed a significantly higher score at the infra-
genicular arterial level in group A (p  0.001).
Conclusion: Findings suggest that the long-term corticosteroid ther-
apy is associated with a distally accentuated, calcifying peripheral atheroscle-
rosis inducing arterial incompressibility. This occlusion pattern is compara-
ble to patients with renal failure or diabetes. Further research is required to
support our observations.
Clinical Outcome of Acute Leg Ischaemia Due to Thrombosed Popli-
teal Artery Aneurysm: Systematic Review of 895 Cases
Kropman R.H.J., Schrijver A.M., Kelder J.C., Moll F.L., de Vries J.P.P.M.
Eur J Vasc Endovasc Surg 2010;39:452-7.
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 4 Abstracts 1067Objectives: A systematic review was performed to summarise out-
comes of acute thrombosed popliteal artery aneurysms (PAAs) treated with
thrombolysis or thrombectomy followed by bypass.
Methods: A systematic review was conducted of data on acute throm-
bosed PAAs dated 1 January 1990 through 30 June 2008 using the
Cochrane Library, MEDLINE and EMBASE databases. Primary endpoint
was limb salvage; secondary endpoints were mortality and patency of the
bypasses.
Results: Eight prospective studies and 25 retrospective studies with
895 patients presenting with acute ischaemia were included. No randomised
trials were included. The mortality rate after surgical repair was 3.2% (95%
confidence interval (C.I.) 1.8–4.6). The amputation rate was 14.1% (95%
C.I. 11.8–16.4). Thrombolysis before surgery did not result in a significant
reduction of the number of amputations, compared with surgery (throm-
bectomy and bypass) alone. The mean primary patency rates of the bypasses
at 1, 3 and 5 years were 79%, 77% and 74%, respectively, in the ‘thrombol-
ysis’ group and 71% (P  0.026), 54% (P  0.164) and 45% (P  0.249) in
the ‘thrombectomy’ group. No distinction could be made regarding sec-
ondary patency and limb-salvage rates between the groups owing to insuf-
ficient data.
Conclusions: Preoperative and intra-operative thrombolyses result in a
significant improvement in 1-year primary graft patency rates, but do not result
in a significant reduction for amputations compared with surgery alone.
Review of Direct Anatomical Open Surgical Management of Athero-
sclerotic Aorto-Iliac Occlusive Disease
Chiu K.W.H., Davies R.S.M., Nightingale P.G., Bradbury A.W., AdamD.J.
Eur J Vasc Endovasc Surg 2010;39:460-71.
Background: Aortofemoral bypass(AFB), iliofemoral bypass(IFB),
and aortoiliac endarterectomy(AIE) are the three most common techniques
for anatomical open surgical revascularisation for patients with aorto-iliac
occlusive disease(AIOD), but the optimal method of reconstruction is
unknown.
Aims: To review and compare mortality, morbidity and short- and
long-term patency rates for AFB, IFB and AIE in patients with AIOD
reported in the English language literature.
Methods: A MEDLINE(1970–2007) and Cochrane Library search
for articles relating to AFB, IFB, AIE and AIOD was undertaken. Studies
were included if: a) patency rates based on life-tables were available, and b)
patient/study characteristics were reported.
Results: 29 studies(5738 patients) for AFB, 11 studies(778 patients)
for IFB and 11 studies(1490 patients) for AIE were included. Operative
mortality was 4.1% for AFB, 2.7% for IFB and 2.7% for AIE (p  0.0001).
Systemic morbidity was 16.0% for AFB, 18.9% for IFB and 12.5% for AIE
(p  0.05). Overall 5-year primary patency rates were 86.2%, 85.3% and
88.2% for AFB, IFB and AIE, respectively (p  NS).
Conclusion: Aorto-iliac endarterectomy was associated with signifi-
cantly lower peri-operative morbidity and mortality rates compared withReaders can access EJVES articles at http://intl.eImmunomodulation of Vascular Diseases: Atherosclerosis and
Autoimmunity
Shi G-P. Eur J Vasc Endovasc Surg 2010;39:485-94.
The autoimmune disease atherosclerosis contributes to several vascular
complications. Besides vascular cells, inflammatory cells occur prominently
in atherosclerotic lesions; lymphocytes play a detrimental role in the initia-
tion and progression of this common vascular disease. Recent discoveries
have led to the identification of several important lymphocyte types within
the atherosclerotic lesions. However, peripheral lymphocytes and those in
the lymphoid organs both figure critically in the regulation of atherosclerotic
lesion growth. Although the concept of atherosclerosis as an autoimmune
disease is well known, the ways in which autoantigens and autoantibodies
contribute to atherogenesis in human or even in animal models remains
largely unknown. For example, autoantigen immunisation can either pro-
mote or attenuate atherogenesis in animals, depending on the antigen types
and the routes and carriers of immunisation. This article summarises recent
findings regarding lesion inflammatory cell types, autoantigens and autoan-
tibody isotypes that can affect the initiation and progression of atheroscle-
rosis from both human and animal studies.
Randomised Clinical Trial of Foam Sclerotherapy for Patients with a
Venous Leg Ulcer
O’Hare J.L., Earnshaw J.J. Eur J Vasc Endovasc Surg 2010;39:495-9.
Objectives: To assess whether routine use of foam sclerotherapy, in
addition to four-layer compression bandaging, could speed up the healing of
venous ulcers.
Design: Randomised controlled trial involving patients recruited from
a nurse-led leg ulcer clinic. A total of 315 new patients were assessed, and
eleven patients were identified from follow-up clinics.
Methods: Inclusion criteria were: patients with an active venous leg
ulcer, in the presence of superficial truncal venous incompetence and with-
out total deep venous incompetence on duplex imaging. Patients were
randomised to four-layer compression bandages alone (control) or with
additional foam sclerotherapy to incompetent superficial truncal veins. The
primary endpoint was ulcer healing 24 weeks after randomisation.
Results: It was only possible to recruit 40 patients who were suitable
for analysis: 22 control, 18 additional foam sclerotherapy. There was no
complication from the foam treatment and at six months the target vein was
occluded in 9 of 11 evaluable patients that had foam. One patient died
before 24 weeks from an unrelated cause. At 24 weeks, 17 of 20 (85% - 1
died) in the control group and 12 of 13 (92%) patients with additional foam
sclerotherapy had ulcer healing (P0.72, log rank testing).
Conclusion: This trial failed to recruit sufficient patients for formal
comparison, but foam sclerotherapy was feasible as an adjunct to compres-bypass grafting. All three techniques were equally effective in terms of
long-term patency.
sion therapy for venous ulceration. Trial registration: Eudra CT 2005-
001551-38lsevierhealth.com/journals/ejvs/default.cfm
